In the Press

pi Ventures: Our Seed Investment in immunitoAI: AI powered Antibody Discovery & Screening

[September 9, 2021] Healthcare today is moving towards targeted therapies as they are more effective and have lesser side effects compared to the traditional treatments. Antibodies are an emerging candidate for targeted therapy and have shown promise... Read more from pi Ventures

The Economic Times: Biotech startup immunitoAI raises $1 million in seed funding

[Sep 09, 2021, 06:39 PM IST] The company provides services to pharmaceutical companies that use artificial intelligence to discover and identify antibodies. Antibody therapy uses synthetic version of the body's antibodies that are supposed to help treat diseases such as cancer and autoimmune disorders... Read more on The Economic Times

YourStory: [Funding alert] Biotech startup immunitoAI raises $1M in seed round led by pi Ventures

[September 9, 2021] immunitoAI, a biotech startup that is developing an AI-powered antibody discovery and screening platform, announced on Wednesday that it has raised $1 million in a seed round... Read more on YourStory

YourStory: [Funding alert] Entrepreneur First announces pre-seed investment in 8 Indian tech startups

[March 18, 2021] Global talent investor Entrepreneur First (EF), on Thursday, announced a pre-seed investment of $440,000 in eight tech startups from its fourth cohort in India... Read more on YourStory

Disclaimer: All the contents on the "In the Press" page belong to the websites in which the articles were published. immunitoAI does not own the rights to any of the contents published in the websites.